154: A PHARMACOECONOMIC EVALUATION TO MAKE DECISION: IS THE USE OF SIMVASTATIN 10 MG AS AN OTC MEDICATION COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF STROKE AMONGST WOMEN IN IRAN? [PDF]
, 2017 Mohammadreza Amirsadri, Niloufar Dorri
openalex +1 more source
Correction: Health technology assessment of surgical robots: a mini-review of a rapidly evolving field. [PDF]
Front Public HealthZhang T, Zhong Y, Zeng J, Liu GG.
europepmc +1 more source
Correction: Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy. [PDF]
Pharmacoecon OpenSalcedo J +7 more
europepmc +1 more source
A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine
, 2015 Rahul Bhambri +4 more
openalex +2 more sources
Inclusion of Pharmacoeconomics course in the Undergraduate Pharmacy Education: A Global Trend Review [PDF]
, 2016 Dixon Thomas +3 more
openalex +1 more source
Correction: Exploring the Economic Burden of Pulmonary Arterial Hypertension and Its Relation to Disease Severity and Treatment Escalation: A Systematic Literature Review. [PDF]
PharmacoeconomicsRamani G +6 more
europepmc +1 more source
Correction: A Framework for Using Cost‑effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence. [PDF]
PharmacoeconomicsWoods B, Palacios A, Sculpher M.
europepmc +1 more source
Cost-effectiveness of hypofractionated radiation therapy versus conventional radiation therapy for unresectable stage III non-small cell lung cancer. [PDF]
Sci RepZhang H +5 more
europepmc +1 more source